Ixomida
Hormonal antineoplastic agent Antiandrogen indicated for the treatment of patients with metastatic castration-sensitive prostate cancer or with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of progression.
Reglicat
Antineoplastic. EGFR, tyrosine kinase inhibitor. Indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR-activating mutations.
Dafex
Antineoplastic, anti-HER2 monoclonal antibody indicated for HER2+ breast cancer and advanced gastric cancer.
Gineva
Antineoplastic agent. Indicated as treatment for specific tumors in adults (advanced RH+ breast cancer, renal cancer, subependymal giant cell astrocytoma, advanced neuroendocrine tumors), and to prevent the growth of other noncancerous cells associated with a genetic disorder called tuberous sclerosis (TS) in children or adults.
Perciclib
Antineoplastic cyclin-dependent kinase (CDK) inhibitor indicated for the treatment of patients with hormone receptor positive advanced breast cancer (HR+HER2-).
Elefix
Surprex
Zalutex
Hormonal antineoplastic indicated for oral treatment of prostate cancer patients.
Novex
Antineoplastic. Anti CD20 monoclonal antibody indicated to treat oncohematologic neoplasms such as Non Hodgkin Lymfom, chronic Lymphocytic Leukemia. Rheumatoid arthritis treatment.
